Maze Therapeutics, Inc. (MAZE) vs Vir Biotechnology, Inc. (VIR)
- Maze Therapeutics, Inc. MAZE 32.01 −1.75%
- Vir Biotechnology, Inc. VIR 10.46 −1.04%
Maze Therapeutics, Inc. and Vir Biotechnology, Inc. are both Biotechnology companies. Maze Therapeutics, Inc. and Vir Biotechnology, Inc. are of similar size ($1.8B and $1.8B). Maze Therapeutics, Inc. has the higher net margin (0.00% vs −83.0%) and the lower return on invested capital (−112.4% vs −39.1%). Across the 13 metrics below, Vir Biotechnology, Inc. leads on 7 and Maze Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | MAZE | VIR | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.77% |
| Operating margin | 0.00% | (92.40%) | 0.00% |
| Net margin | 0.00% | (83.00%) | 0.00% |
| Free cash flow margin | 0.00% | (67.17%) | 0.00% |
| Return on equity | (37.35%) | (26.08%) | (54.09%) |
| Return on assets | (31.99%) | (20.91%) | (47.78%) |
| Return on invested capital | (112.36%) | (39.10%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack